National Service Plan is a hopeful wish-list of good things, and unclear on the rest

The National Service Plan for the Health Service Executive outlines the HSE's plans for the year 2024, but the implementation of these plans is uncertain. The government has allocated €23.5…

admin admin

Lubiprostone, Linaclotide, and Elobixibat Improve Chronic Constipation

Lubiprostone, linaclotide, and elobixibat increase the mean spontaneous bowel movement (SBM) frequency in patients with chronic constipation (CC), according to a study in BMC Gastroenterology. The study reviewed 24 articles…

admin admin

Contributed: ​​The role of digital innovation in healthcare boardrooms

The evolving healthcare landscape requires board members to guide digital innovation strategies, anticipate risks, and make informed decisions. Board members must understand the digital landscape, anticipate future trends, make strategic…

admin admin

Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers

David Mitchell, a multiple myeloma patient, has been paying exorbitant amounts for his needed medication. This led him to found the advocacy group Patients for Affordable Drugs, which in part…

admin admin

FDA grants device for treatment of chronic limb-threatening ischemia breakthrough status

The FDA has granted breakthrough device status to Efemoral Medical's novel vascular scaffold system for the treatment of chronic limb-threatening ischemia. The system, called Efemoral Vascular Scaffold System, is designed…

admin admin

Secretariat’s lessons for human medicine

STAT publishes selected Letters to the Editor in response to First Opinion essays to encourage robust discussion about difficult issues. The current issue includes articles about the dental care crisis,…

admin admin

Lauren Phillips | The BMJ

Lauren Philips was a dedicated doctor who started her career in Truro and later worked in intensive care and accident and emergency medicine at Southmead Hospital in Bristol. She tragically…

admin admin

Trial data underpins FDA approval of omalizumab for food allergy

The Food and Drug Administration approved omalizumab to reduce allergic reactions and anaphylaxis in people with food allergies. The approval was based on data from a Phase 3 clinical trial…

admin admin

Exome sequencing unravels complex genetic diagnoses in growth disorders

A study conducted by researchers at the University of São Paulo's Medical School found that using exome sequencing to diagnose growth disorders in children with overlapping symptoms and conditions is…

admin admin

A New Guide to Healthy Eating

Experts recommend prioritizing a variety of colorful fruits and vegetables in your diet for optimal health. Each color group provides different nutrients and benefits, such as antioxidants, anti-inflammatory properties, and…

admin admin
error: Content is protected !!